TEACHERS ADVISORS, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$2,583,000
+4.7%
317,364
+3.8%
0.00%0.0%
Q4 2018$2,467,000
-45.2%
305,727
-48.1%
0.00%0.0%
Q3 2018$4,498,000
+177.3%
589,572
+108.3%
0.00%
+50.0%
Q2 2018$1,622,000
+25.4%
283,104
+4.4%
0.00%0.0%
Q1 2018$1,293,000
-2.5%
271,137
+0.4%
0.00%0.0%
Q4 2017$1,326,000
+25.3%
269,999
+33.7%
0.00%
+100.0%
Q3 2017$1,058,000
-3.1%
201,879
+2.8%
0.00%
-50.0%
Q2 2017$1,092,000
+3.2%
196,385
+55.9%
0.00%0.0%
Q1 2017$1,058,000
+32.9%
125,947
+0.1%
0.00%
+100.0%
Q4 2016$796,000
+70.1%
125,777
+18.5%
0.00%0.0%
Q3 2016$468,000
+40.5%
106,162
-9.6%
0.00%0.0%
Q2 2016$333,000
+9.9%
117,398
+9.7%
0.00%0.0%
Q1 2016$303,000
-93.0%
107,034
-74.4%
0.00%
-87.5%
Q4 2015$4,315,000
-9.5%
418,1340.0%0.01%
-20.0%
Q3 2015$4,767,000
+202.9%
418,134
+296.6%
0.01%
+233.3%
Q2 2015$1,574,000
+74.1%
105,420
+5.3%
0.00%
+50.0%
Q1 2015$904,000
-24.3%
100,074
+1.9%
0.00%0.0%
Q4 2014$1,194,000
+24.4%
98,1830.0%0.00%0.0%
Q3 2014$960,000
-23.3%
98,1830.0%0.00%
-33.3%
Q2 2014$1,252,00098,1830.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Burrage Capital Management LLC 864,916$13,674,00013.71%
Sarissa Capital Management LP 4,261,000$67,366,0005.36%
ORACLE INVESTMENT MANAGEMENT INC 1,920,733$30,367,0004.18%
HealthCor Management, L.P. 3,248,100$51,352,0002.05%
Parkman Healthcare Partners LLC 351,961$5,565,0001.22%
Bain Capital Public Equity Management II, LLC 1,560,730$24,675,0001.06%
Baker Brothers Advisors 12,710,818$200,958,0000.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,835,000$44,821,0000.80%
Biondo Investment Advisors, LLC 265,840$4,203,0000.72%
EAM Global Investors LLC 157,065$2,483,0000.69%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders